@article{hallquist_application_2021,
 abstract = {BACKGROUND: Genetic information is increasingly relevant across healthcare. Traditional genetic counseling (GC) may limit access to genetic information and may be more information and support than some individuals need. We report on the application and clinical implications of a framework to consistently integrate genetics expertise where it is most useful to patients.
METHODS: The Clinical Genome Resource's (ClinGen) Consent and Disclosure Recommendations (CADRe) workgroup designed rubrics to guide pre- and post-genetic test communication. Using a standard set of testing indications, pre- and post-test rubrics were applied to 40 genetic conditions or testing modalities with diverse features, including variability in levels of penetrance, clinical actionability, and evidence supporting a gene-disease relationship. Final communication recommendations were reached by group consensus.
RESULTS: Communication recommendations were determined for 478 unique condition-indication or testing-indication pairs. For half of the conditions and indications (238/478), targeted discussions (moderate communication depth) were the recommended starting communication level for pre- and post-test conversations. Traditional GC was recommended pre-test for adult-onset neurodegenerative conditions for individuals with no personal history and post-test for most conditions when genetic testing revealed a molecular diagnosis as these situations are likely higher in complexity and uncertainty. A brief communication approach was recommended for more straightforward conditions and indications (e.g., familial hypercholesterolemia; familial variant testing).
CONCLUSIONS: The CADRe recommendations provide guidance for clinicians in determining the depth of pre- and post-test communication, strategically aligning the anticipated needs of patients with the starting communication approach. Shorter targeted discussions or brief communications are suggested for many tests and indications. Longer traditional GC consultations would be reserved for patients with more complex and uncertain situations where detailed information, education, and psychological support can be most beneficial. Future studies of the CADRe communication framework will be essential for determining if CADRe-informed care supports quality patient experience while improving access to genetic information across healthcare.},
 author = {Hallquist, Miranda L. G. and Tricou, Eric P. and Ormond, Kelly E. and Savatt, Juliann M. and Coughlin, Curtis R. and Faucett, W. Andrew and Hercher, Laura and Levy, Howard P. and O'Daniel, Julianne M. and Peay, Holly L. and Stosic, Melissa and Smith, Maureen and Uhlmann, Wendy R. and Wand, Hannah and Wain, Karen E. and Buchanan, Adam H.},
 doi = {10.1186/s13073-021-00887-x},
 file = {Full Text:C\:\\Users\\Curtis\\Zotero\\storage\\RKIENK53\aÌ‹llquist et al. - 2021 - Application of a framework to guide genetic testing communication across clinical indications.pdf:application/pdf},
 issn = {1756-994X},
 journal = {Genome Med},
 keywords = {Access, Communication, Disclosure, Genetic counseling, Genetic testing, Genetic Testing, Humans, Informed consent, Informed Consent, Results disclosure, Service delivery},
 language = {eng},
 month = {April},
 number = {1},
 pages = {71},
 pmcid = {PMC8086064},
 pmid = {33926532},
 title = {Application of a framework to guide genetic testing communication across clinical indications},
 volume = {13},
 year = {2021}
}
